Results 201 to 210 of about 373,406 (347)
Targeted Expansion of Treg Cells to Induce Immune Tolerance after Kidney Transplantation
A dual‐targeting nanoparticle platform that selectively engages graft stromal cells via CD248 receptors while employing kidney‐ specific promoters (NPHS2) to drive localized IL‐ 2/TGF‐βexpression is developed. This approach achieves three therapeutic objectives:1) intragraft Treg polarization without systemic cytokine exposure;2) reduced dependence on ...
Tong Lu +18 more
wiley +1 more source
Metabolic regulation of immune memory and function of microglia. [PDF]
Nirakis N +3 more
europepmc +1 more source
Impaired Phagocytosis in Peritonitis Exudate Secondary to Complement Consumption [PDF]
Billing, A. +3 more
core +1 more source
Repurposing cardiac glycosides (CGs) significantly strengthens the efficacy of anti‐CD47 antibody for lung cancer treatment by boosting macrophage phagocytosis. This novel combination blocks the “don't eat me” signal and increases dual “eat‐me” signals, Fc‐FcγR and cell surface expression of calreticulin (ecto‐CRT).
Zi‐Han Ye +9 more
wiley +1 more source
Phage receptor binding protein and Fc fragment fusion enhances phagocytosis of Y. enterocolitica. [PDF]
Filik-Matyjaszczyk K +5 more
europepmc +1 more source
PHAGOCYTOSIS, WITH PARTICULAR REFERENCE TO ENCAPSULATED BACTERIA [PDF]
W. Barry Wood
openalex +1 more source
Single‐Cell RNA Sequencing of Thyroid Tissues Reveals Pathogenesis of Graves' Disease
Using single‐cell RNA sequencing and TCR profiling, this study constructed an immune cell atlas in thyroid tissue of Graves’ disease (GD), revealing dominant IFN‐γ‐secreting CD4+ T cells, expanded Tph and CD11c+ B cells, and enriched T/NK cells. Notably, GD thyroid follicular cells (TFCs) activated γδ T cells, which recruited cDC1 cells, suggesting a ...
Xiaoyi Zhou +18 more
wiley +1 more source
S-ketamine relieves neuropathic pain by inhibiting microglia phagocytosis of the perineuronal nets. [PDF]
Yang X +11 more
europepmc +1 more source
This study presents an engineered probiotic platform, iRGD‐mRBC@FOLactis, combining red blood cell membrane cloaking and tumor‐penetrating peptide iRGD for enhanced PD‐1 blockade. The platform improves tumor targeting, immune cell activation and therapeutic efficacy in lung cancer, demonstrating significant promise in overcoming PD‐1/PD‐L1 therapy ...
Chen Chen +9 more
wiley +1 more source

